CCM
NEO icon

Cinctive Capital Management’s NeoGenomics NEO Stock Holding History

Cinctive Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-82,542
Closed -$711K – 487
2022
Q3 		$711K Buy
+82,542
New +$820K 0.03% 369

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Cinctive Capital Management's NEO Position: Q4 2022 in Review

Cinctive Capital Management sold out of NeoGenomics (NEO) in Q4 2022, closing a stake of 82,542 shares — an estimated $711K sold.

Cinctive Capital Management first reported a position in NEO in Q3 2022 and held it in 1 quarter. The position peaked at $711K in Q3 2022. 242 funds tracked by Wall St. Rank hold NEO as of Q4 2022.

  • Cinctive Capital Management reported no remaining NeoGenomics position as of Q4 2022 after selling out during the quarter.
  • Cinctive Capital Management sold 82,542 NeoGenomics shares in Q4 2022, an estimated $711K.
  • Cinctive Capital Management first reported a position in NeoGenomics in Q3 2022 and held it in 1 quarter.
  • Cinctive Capital Management's NeoGenomics position peaked at $711K in Q3 2022.
  • 242 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2022.

Based on Cinctive Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.